Abstract
Moyamoya disease is a rare cerebrovascular condition involving stenotic carotid arteries and the formation of abnormal blood vessels. In this study, we aimed to characterize the key players involved in moyamoya research at the individual and institutional level and to identify the critical publications that have advanced our understanding of this disease. We performed a title-specific search of the Web of Science database using the search term “moyamoya” for publications dating from 1900 to April 2020. The 100 most frequently cited articles were obtained, screened for duplicates, and reviewed by 2 independent reviewers. These 100 articles were cited an average of 150 times each (range, 74 to 1,360 citations per article). Publication dates ranged from 1969 to 2016, with the largest number of publications (n=40) cited between 2000 and 2009. The article with the greatest number of citations (1,360 citations) was “Cerebrovascular ‘moyamoya’ disease: disease showing abnormal net-like vessels in base of brain,” by Suzuki and Takaku, published in the Archives of Neurology, 1969. Stroke published the greatest number of the most frequently cited articles (23 of 100). The institution that contributed the most articles was Tohoku University (16%); the majority of the most frequently cited articles originated in Japan (62%). We identified the 100 most cited articles on moyamoya disease over the past 51 years to recognize significant and impactful works. These results can be used as a guide to evaluate our current understanding of moyamoya disease and to direct future efforts.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
Bohl MA, Ponce FA (2017) Assessing the relevancy of highly cited works in neurosurgery. Part I: the 100 most relevant papers in neurosurgical journals. World Neurosurg 104:927–938
Choudhri AF, Siddiqui A, Khan NR, Cohen HL (2015) Understanding bibliometric parameters and analysis. RadioGraphics 35:736–746
Fujimura M, Bang OY, Kim JS (2016) Moyamoya disease. Front Neurol Neurosci 40:204–220
Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 Suppl 2:S238–S240
Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS et al (2009) Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 84:617–627
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111:927–935
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56:34–40
Karasawa J, Kikuchi H, Furuse S, Kawamura J, Sakaki T (1978) Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 49:679–688
Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42–47
Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056–1066
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M et al (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6:e22542
Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC (2014) Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45:1415–1421
Park KM, Kim JE, Kim Y, Kim SE, Yoon DY, Bae JS (2017) Searching the footprints of pioneers on neurology: a bibliometric analysis. Eur Neurol 77:152–161
Ponce FA, Lozano AM (2010) Highly cited works in neurosurgery. Part I: the 100 top-cited papers in neurosurgical journals. 112:223
Röhrig B, du Prel J-B, Wachtlin D, Blettner M (2009) Types of study in medical research: part 3 of a series on evaluation of scientific publications. Deutsches Arzteblatt Int 106:262–268
Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100:142–149
Suzuki J, Kodama N (1983) Moyamoya disease--a review. Stroke 14:104–109
Suzuki J, Takaku A (1969) Cerebrovascular "moyamoya" disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299
Takeuchi K, K. S (1957) Hypoplasia of the bilateral internal carotid arteries. Brain Nerve (Tokyo) 9:37–43
van Raan T (2004) Chapter 1 Measuring science capita selecta of current main issues. Handbook of Quantitative Science and Technology Research. Kluwer Publishers, pp 19–50
Zhang H, Zheng L, Feng L (2019) Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med 17:1977–1984
Acknowledgements
We thank the staff of Neuroscience Publications at Barrow Neurological Institute for assistance with manuscript preparation.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study.
Conception and design: RS, MDM, NMD, JRP
Acquisition of data: RS, MDM, NMD, JRP
Analysis and interpretation of data: RS, MDM, NMD, JRP, JSC, VMS, RR, MTL
Drafting the article: RS, MDM, NMD, JRP
Critically revising the article: RS, MDM, NMD, JRP, JSC, VMS, RR, MTL
Reviewed final version of the manuscript and approved it for submission: RS, MDM, NMD, JRP, JSC, VMS, RR, MTL
Statistical analysis: N/A
Administrative/technical/material support: JSC, VMS, RR, MTL
Study supervision: JSC, VMS, RR, MTL
Corresponding author
Ethics declarations
Ethics approval
No human or animal participants were involved in this literature review. In addition, no patient data were reported. IRB approval was not required as our review did not involve any human/animal subjects.
Consent to participate
Not applicable. Our study did not involve any human individual subjects.
Competing interests
The authors declare no competing interests. No patient data are included in this manuscript.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplemental Figure 1
Flow chart illustrating the literature review process. (PNG 161 kb)
ESM 1
(DOCX 42 kb)
Rights and permissions
About this article
Cite this article
Singh, R., McLelland, M.D., De La Peña, N.M. et al. Research advances in the diagnosis and treatment of moyamoya disease: a bibliometric analysis. Neurosurg Rev 45, 1977–1985 (2022). https://doi.org/10.1007/s10143-022-01748-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-022-01748-w